title: [Neuroboreliosis with motoric disturbations in the developmental age].
abstract: BACKGROUND
  Neurological symptoms develop in 10-20% of children suffered borreliosis (LD).
  
  
  OBJECTIVE
  It was a presentation of motoric disturbances of neuroboreliosis in children.
  
  
  METHODS
  Children with neuroborreliosis and other neurological diseases were admitted to the University hospital during 2005-2007. Of these 13 patients, there were 9 males and 4 females, ranging in age between 3-17 years. Neurological diagnostic was performed using ELISA Biomedica kit and western blot bands. A 2-6 week sequential treatment with either iv ceftazidime or amoxicillin and oral doxycycline or amoxicillin was provided. Children were monitored regularly during the next 4-36 months.
  
  
  RESULTS
  The 13 children with neuroborreliosis constitute 0.5% of the pediatric neurology department's patients. The clinical manifestation of LD were usual and unusual from patient to patient. They included four cases of facial nerve paralysis (with bilateral paralysis in one case), in three cases transverse myelitis and in a single case, hemiparesis, and oculomotor nerve paresis. In 9/13 children motoric disturbances of neuroboreliosis was diagnosed indeed. The antibiotic treatment was successful in 6 patients and only partially effective in 3 children with facial nerve paralysis.
  
  
  CONCLUSIONS
  The most common symptoms of neuroborreliosis in children was motoric dysfunction.
authors.affiliation: Klinika Neurologii Dzieciecej, Uniwersytet Jagielloński Collegium Medicum, Kraków. neupedkr@cm-uj.krakow.pl
authors.forename: Barbara
authors.initials: B
authors.lastname: Skowronek-Bała
authors.forename: Ewa
authors.initials: E
authors.lastname: Wesołowska
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Gergont
authors.forename: Marek
authors.initials: M
authors.lastname: Kaciński
mesh_terms: D000293:Adolescent; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004318:Doxycycline / Q000627:therapeutic use; D005158:Facial Paralysis / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D020852:Lyme Neuroborreliosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000658:Amoxicillin; D002442:Ceftazidime; D004318:Doxycycline